Adult central nervous system germinoma

Summary

Adult central nervous system germinoma (MONDO:0004383) is a disease. A subtype of central nervous system germinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	adult central nervous system germinoma
Mondo ID	MONDO:0004383
DOID	DOID:7867
NCIT	C5792
UMLS	C1370504
MedGen	234581
GARD	0023970
Is cancer (heuristic)	no

Also known as: adult central nervous system germinoma · adult CNS germinoma · central nervous system germinoma · central nervous system germinoma of adults · germinoma of adult central nervous system · germinoma of adult CNS · germinoma of the adult central nervous system · germinoma of the adult CNS

Disease family

This is a subtype of central nervous system germinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › central nervous system germinoma › adult central nervous system germinoma

Related subtypes (2): brain germinoma, childhood central nervous system germinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.